Literature DB >> 22301027

Glutamate dehydrogenase is highly conserved among Clostridium difficile ribotypes.

R J Carman1, K N Wickham, L Chen, A M Lawrence, J H Boone, T D Wilkins, T M Kerkering, D M Lyerly.   

Abstract

gluD was highly conserved and glutamate dehydrogenase (GDH) was readily expressed in vitro by all 77 Clostridium difficile ribotypes assayed. All ribotypes, including ARL 002, ARL 027, and ARL 106, were reactive in assays that detect C. difficile GDH.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22301027      PMCID： PMC3318512          DOI： 10.1128/JCM.05600-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  2 in total

1.  PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes.

Authors:  S L Stubbs; J S Brazier; G L O'Neill; B I Duerden
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

2.  Lack of effect of strain type on detection of toxigenic Clostridium difficile by glutamate dehydrogenase and polymerase chain reaction.

Authors:  Simon D Goldenberg; Maria Gumban; Anthony Hall; Amita Patel; Gary L French
Journal:  Diagn Microbiol Infect Dis       Date:  2011-07       Impact factor: 2.803
  2 in total
  13 in total

Review 1.  Primary Prevention of Clostridium difficile-Associated Diarrhea: Current Controversies and Future Tools.

Authors:  Zachary A Rubin; Elise M Martin; Paul Allyn
Journal:  Curr Infect Dis Rep       Date:  2018-06-29       Impact factor: 3.725

2.  Comparison of the Vidas C. difficile GDH Automated Enzyme-Linked Fluorescence Immunoassay (ELFA) with Another Commercial Enzyme Immunoassay (EIA) (Quik Chek-60), Two Selective Media, and a PCR Assay for gluD for Detection of Clostridium difficile in Fecal Samples.

Authors:  K A Davies; C E Berry; K A Morris; R Smith; S Young; T E Davis; D D Fuller; R J Buckner; M H Wilcox
Journal:  J Clin Microbiol       Date:  2015-03-18       Impact factor: 5.948

Review 3.  Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.

Authors:  Ying M Tang; Christian D Stone
Journal:  Clin J Gastroenterol       Date:  2017-02-16

Review 4.  Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.

Authors:  Carey-Ann D Burnham; Karen C Carroll
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

Review 5.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  Premarket evaluations of the IMDx C. difficile for Abbott m2000 Assay and the BD Max Cdiff Assay.

Authors:  K A Stellrecht; A A Espino; V P Maceira; S M Nattanmai; S A Butt; D Wroblewski; G E Hannett; K A Musser
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

7.  Comparison of Simplexa universal direct PCR with cytotoxicity assay for diagnosis of Clostridium difficile infection: performance, cost, and correlation with disease.

Authors:  Marie L Landry; David Ferguson; Jeffrey Topal
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

8.  Outbreak of Clostridium difficile PCR ribotype 027--the recent experience of a regional hospital.

Authors:  Mónica Oleastro; Marta Coelho; Marília Gião; Salomé Coutinho; Sandra Mota; Andrea Santos; João Rodrigues; Domitília Faria
Journal:  BMC Infect Dis       Date:  2014-04-17       Impact factor: 3.090

9.  Extraction and sensitive detection of toxins A and B from the human pathogen Clostridium difficile in 40 seconds using microwave-accelerated metal-enhanced fluorescence.

Authors:  Lovleen Tina Joshi; Buddha L Mali; Chris D Geddes; Les Baillie
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

10.  Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027.

Authors:  Alan M McGovern; Grace O Androga; Daniel R Knight; Mark W Watson; Briony Elliott; Niki F Foster; Barbara J Chang; Thomas V Riley
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.